Paul Knight
Stock Analyst at Keybanc
(2.41)
# 2,492
Out of 4,937 analysts
135
Total ratings
47.32%
Success rate
-2.21%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Overweight | $15 | $7.56 | +98.41% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $9.20 | +84.78% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $117.58 | +14.82% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.53 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $50.42 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $281.20 | +63.58% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.31 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $240.98 | +34.87% | 11 | Feb 14, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Overweight | $8 | $3.40 | +135.29% | 1 | Feb 12, 2025 | |
| RVTY Revvity | Maintains: Overweight | $132 → $145 | $86.84 | +66.97% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $189.43 | +121.72% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $101.68 | +126.20% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $22.68 | +45.50% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $19.36 | +85.95% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $200.56 | +54.57% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $111.43 | +97.43% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $460.72 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $23.63 | +56.58% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.20 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.23 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $114.62 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $29.00 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.50 | +247.83% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $148.74 | +101.69% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $179.86 | +39.00% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $118.41 | +272.43% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $112.85 | +109.13% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $70.29 | +40.85% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $10.82 | +408.32% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $27.37 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $64.44 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $94.56 | - | 5 | Oct 23, 2017 |
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $7.56
Upside: +98.41%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $9.20
Upside: +84.78%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $117.58
Upside: +14.82%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.53
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $50.42
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $281.20
Upside: +63.58%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.31
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $240.98
Upside: +34.87%
Rapid Micro Biosystems
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.40
Upside: +135.29%
Revvity
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $86.84
Upside: +66.97%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $189.43
Upside: +121.72%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $101.68
Upside: +126.20%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $22.68
Upside: +45.50%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $19.36
Upside: +85.95%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $200.56
Upside: +54.57%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $111.43
Upside: +97.43%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $460.72
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $23.63
Upside: +56.58%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.20
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.23
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $114.62
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $29.00
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.50
Upside: +247.83%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $148.74
Upside: +101.69%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $179.86
Upside: +39.00%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $118.41
Upside: +272.43%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $112.85
Upside: +109.13%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $70.29
Upside: +40.85%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $10.82
Upside: +408.32%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $27.37
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $64.44
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $94.56
Upside: -